For two months, the US-based Duke University Global Health Innovation Centre (GHIC) has been tracking and publishing the purchase of anti-COVID 19 vaccines.
Their findings show that rich countries - which account for around only 14 per cent of the world's population - have secured more than half of the most promising vaccines. What are the implications for global health?
Listen to SBS Indonesian every Monday, Wednesday, Friday and Sunday at 3 pm. Follow us on Facebook and catch us on podcasts.
And you can keep abreast of the latest information about the corona virus in your language at sbs.com.au/coronavirus
Share
